Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current and future therapies for gout
Tristan Pascart, Pascal Richette
Expert Opinion on Pharmacotherapy (2017) Vol. 18, Iss. 12, pp. 1201-1211
Closed Access | Times Cited: 47

Showing 26-50 of 47 citing articles:

Comparative efficacy and safety of uricosuric agents in the treatment of gout or hyperuricemia: a systematic review and network meta-analysis
Ya-Jia Li, Lirong Chen, Zhong-Lei Yang, et al.
Clinical Rheumatology (2022) Vol. 42, Iss. 1, pp. 215-224
Closed Access | Times Cited: 7
Proline-derived quinoline formamide compounds as human urate transporter 1 inhibitors with potent uric acid-lowering activities
Shengnan Li, Hui Liao, Lijun Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116327-116327
Closed Access | Times Cited: 1
Gout risk in adults with pre-diabetes initiating metformin
Javier Marrugo, L Santacroce, Misti L. Paudel, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 10, pp. 1368-1374
Open Access | Times Cited: 1
Unraveling the impact of miRNAs on gouty arthritis: diagnostic significance and therapeutic opportunities
Sherif S. Abdel Mageed, Hanan Elimam, Ahmed E. Elesawy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access | Times Cited: 1
Lumbar spinal stenosis attributable to tophaceous gout: case report and review of the literature
Wei Wang, Qingbo Li, Lei Cai, et al.
Therapeutics and Clinical Risk Management (2017) Vol. Volume 13, pp. 1287-1293
Open Access | Times Cited: 9
Adult-onset systemic autoinflammatory disorders: a clinical approach
Tiago Borges, Adriana Nunes da Silva Barbosa, S. Silva
Reumatismo (2020) Vol. 71, Iss. 4, pp. 177-188
Open Access | Times Cited: 9
Erodium birandianum Ilarslan & Yurdak. shows anti-gout effect through xanthine oxidase inhibition: Combination of in vitro and in silico techniques and profiling of main components by LC-Q-ToF-MS
Elif Baki Kekilli, İlkay Erdoğan Orhan, Fatma Sezer Şenol, et al.
Phytochemistry Letters (2021) Vol. 43, pp. 80-87
Closed Access | Times Cited: 7
Efficacy and safety of urate‐lowering treatments in patients with hyperuricemia: A comprehensive network meta‐analysis of randomized controlled trials
Shanshan Sun, Donghu Zhang, Yue Shi, et al.
Journal of Clinical Pharmacy and Therapeutics (2020) Vol. 45, Iss. 4, pp. 729-742
Open Access | Times Cited: 6
Diagnosis and Treatment of Patellar Tendon Gouty Tophus: A Case Report
Theodoros Bouras, Maulik Gandhi, Andrew Barnett
The Surgery Journal (2019) Vol. 05, Iss. 02, pp. e46-e49
Open Access | Times Cited: 5
Standardization of Diploid Codonopsis laceolata Root Extract as an Anti-Hyperuricemic Source
Seung-Yub Song, So‐Hyeon Bok, Sung-Ho Lee, et al.
Processes (2021) Vol. 9, Iss. 11, pp. 2065-2065
Open Access | Times Cited: 5
Crystal arthropathies
James Stanway, Thiraupathy Marianayagam, Spencer Ellis
Medicine (2018) Vol. 46, Iss. 3, pp. 181-186
Closed Access | Times Cited: 4
Higher Febuxostat Exposure Observed in Asian Compared with Caucasian Subjects Independent of Bodyweight
Dinko Rekić, Susanne Johansson, Jacob Leander
Clinical Pharmacokinetics (2020) Vol. 60, Iss. 3, pp. 319-328
Closed Access | Times Cited: 4
Trends in healthcare utilization by patients with gout: A cross-sectional study using Health Insurance Review and Assessment Service data
Do-Hyun Kang, Yoon Jae Lee, In‐Hyuk Ha, et al.
Medicine (2024) Vol. 103, Iss. 7, pp. e36436-e36436
Open Access
Crystal arthropathies
Sean YW Tan, James Stanway, S. Richard Ellis
Medicine (2021) Vol. 50, Iss. 2, pp. 109-115
Closed Access | Times Cited: 3
Pharmacotherapeutic management of gout in patients with cardiac disease
Chun Wai Chan, Ying Nee Yap
Expert Opinion on Pharmacotherapy (2018) Vol. 19, Iss. 18, pp. 2011-2018
Closed Access | Times Cited: 1
Interrogation of the Perturbed Gut Microbiota in Gouty Arthritis Patients Throughin silicoMetabolic Modeling
Michael A. Henson
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1
In silico Inhibition studies of constituents of Abutilon indicum on Xanthine oxidase
M Guruvigneshwari, Vijaya Bharathi R, R. Radha, et al.
Research Journal of Pharmacy and Technology (2022), pp. 1133-1136
Closed Access | Times Cited: 1
Prevalence of Chronic Kidney Disease and Hyperuricemia in Gout Arthritis Patients
Can Hüzmeli, Meryem Timuçin, Murat Güllü, et al.
Acta Medica Alanya (2019) Vol. 3, Iss. 1, pp. 54-58
Open Access
Gout: Patients, Medicine and Society
Carly A. Janssen
(2019)
Open Access
Prevalence of Chronic Kidney Disease and Hyperuricemia in Gout Arthritis Patients
Can Hüzmeli, Meryem Timuçin, Murat Güllü, et al.
Acta Medica Alanya (2019) Vol. 3, Iss. 1, pp. 54-58
Open Access
Molecular Docking Study of Biologically Active Ligand and the Insights of Synthesis, Characterization and In Vitro Studies of Derivatives of β-tubulin Polymerization Inhibitor as Antigout Agent
Vaishali Gaikwad
Indian Journal of Science and Technology (2020) Vol. 13, Iss. 07, pp. 756-766
Open Access
Host-Population Microbial Diversity Scaling of Chinese Gut Microbiomes in Gout Patients
Jieshang Zhou, Yali Yuan, Pengli Xu, et al.
Evolutionary Bioinformatics (2022) Vol. 18
Open Access
Previous Page - Page 2

Scroll to top